MENU
+Compare
ALXO
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$1.22
Change
+$0.14 (+12.96%)
Capitalization
65.33M

ALXO ALX Oncology Holdings Forecast, Technical & Fundamental Analysis

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials... Show more

ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALXO with price predictions
Sep 05, 2025

Aroon Indicator for ALXO shows an upward move is likely

ALXO's Aroon Indicator triggered a bullish signal on September 05, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 185 similar instances where the Aroon Indicator showed a similar pattern. In of the 185 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on ALXO as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ALXO advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ALXO moved out of overbought territory on September 02, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 46 cases where ALXO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALXO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALXO broke above its upper Bollinger Band on August 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALXO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.014) is normal, around the industry mean (20.143). P/E Ratio (0.000) is within average values for comparable stocks, (52.852). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.088). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (327.233).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALXO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALXO is expected to report earnings to fall 29.49% to -34 cents per share on November 06

ALX Oncology Holdings ALXO Stock Earnings Reports
Q3'25
Est.
$-0.35
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.20
The last earnings report on August 12 showed earnings per share of -49 cents, missing the estimate of -43 cents. With 827.91K shares outstanding, the current market capitalization sits at 65.33M.
A.I. Advisor
published General Information

General Information

a clinical stage company, which engages in the research and development of therapies for cancer patients

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
323 Allerton Avenue
Phone
+1 650 466-7125
Employees
72
Web
https://www.alxoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FAVO1.770.27
+18.00%
Favo Capital, Inc.
EMITF1.80N/A
N/A
Elbit Imaging, Ltd.
OSTIY15.59N/A
N/A
Osterreichische Post AG
WFCNP1.60N/A
N/A
Wells Fargo & Co.
ELEEF26.46-0.08
-0.31%
Element Fleet Mgmt Corp.

ALXO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with NUVB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
+12.96%
NUVB - ALXO
36%
Loosely correlated
+14.04%
ZNTL - ALXO
33%
Poorly correlated
-1.13%
KOD - ALXO
32%
Poorly correlated
+23.04%
NKTX - ALXO
32%
Poorly correlated
+6.10%
MGNX - ALXO
31%
Poorly correlated
+3.09%
More